Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Duensing

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Biochimica Et Biophysica Acta|May 9, 2001
Centrosome abnormalities, genomic instability and carcinogenic progressionS Duensing, K Münger
Blood|April 1, 1995
Increased intracellular and plasma levels of basic fibroblast growth factor in B-cell chronic lymphocytic leukemiaS Duensing, J Atzpodien
Perception|January 1, 1979
The Cheshire Cat effectS Duensing, B Miller
Oncology (Williston Park, N.Y.)|February 1, 1994
Are we obtaining the maximum benefit from GM-CSF and G-CSF?S C Gulati, S Duensing
Cancer Investigation|January 1, 1994
Evaluating the benefit of purging in stem cell transplantationS C Gulati, S Duensing
Cancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Dose distribution of low-dose subcutaneous recombinant interleukin-2 affects the secondary release of interferon-gamma in vivoM Meffert, S Duensing, J Atzpodien
The New England Journal of Medicine|May 16, 1996
P-glycoprotein and multidrug resistanceS Duensing, A Ganser, J Atzpodien
Blood|June 15, 1994
CD39 as a novel marker of in vivo immune activationS Duensing, H Kirshner, J Atzpodien
Anticancer Research|September 1, 1995
Increased serum levels of basic fibroblast growth factor (bFGF) are associated with progressive lung metastases in advanced renal cell carcinoma patientsS Duensing, J Grosse, J Atzpodien
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Loss of VLA-3 (CD49c/CD29) expression in two multidrug resistant Burkitt's lymphoma cell linesS Duensing, A Duensing, J Grosse, et al.
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Biochimica Et Biophysica Acta|May 9, 2001
Centrosome abnormalities, genomic instability and carcinogenic progressionS Duensing, K Münger
Blood|April 1, 1995
Increased intracellular and plasma levels of basic fibroblast growth factor in B-cell chronic lymphocytic leukemiaS Duensing, J Atzpodien
Perception|January 1, 1979
The Cheshire Cat effectS Duensing, B Miller
Oncology (Williston Park, N.Y.)|February 1, 1994
Are we obtaining the maximum benefit from GM-CSF and G-CSF?S C Gulati, S Duensing
Cancer Investigation|January 1, 1994
Evaluating the benefit of purging in stem cell transplantationS C Gulati, S Duensing
Cancer Biotherapy & Radiopharmaceuticals|June 1, 1997
Dose distribution of low-dose subcutaneous recombinant interleukin-2 affects the secondary release of interferon-gamma in vivoM Meffert, S Duensing, J Atzpodien
The New England Journal of Medicine|May 16, 1996
P-glycoprotein and multidrug resistanceS Duensing, A Ganser, J Atzpodien
Blood|June 15, 1994
CD39 as a novel marker of in vivo immune activationS Duensing, H Kirshner, J Atzpodien
Anticancer Research|September 1, 1995
Increased serum levels of basic fibroblast growth factor (bFGF) are associated with progressive lung metastases in advanced renal cell carcinoma patientsS Duensing, J Grosse, J Atzpodien
Cancer Biotherapy & Radiopharmaceuticals|June 14, 2000
Loss of VLA-3 (CD49c/CD29) expression in two multidrug resistant Burkitt's lymphoma cell linesS Duensing, A Duensing, J Grosse, et al.
Pageof 8